Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock.

NCT00148278 is registered in ClinicalTrials.gov with University of Versailles as lead sponsor.

NCT NCT00148278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00148278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock.
Lead sponsor
University of Versailles
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 1999
Completion date
December 31, 2005
Enrollment
330 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

infections, septic shock, severe sepsis